Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
Go back to Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement| (NASDAQ: CRDF) | Delayed: 1.37 +0.07 (5.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.30 | 52 Week High | $ | |||
| Open | $1.29 | 52 Week Low | $ | |||
| Day High | $1.39 | P/E | N/A | |||
| Day Low | $1.29 | EPS | $ | |||
| Volume | 742,259 | |||||

